SOPHARMA AD - The Board of Directors of „Sopharma“ AD approved a prospectus for the issue of warrants

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 56 / 2021

Date of issue: 2021-08-03

Short name of the issuer

SOPHARMA AD

Subject

The Board of Directors of „Sopharma“ AD approved a prospectus for the issue of warrants

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

“Sopharma” AD (the Company) notifies that in accordance with Art. 25 of the Articles of Association of the Company, at its meeting the Board of Directors approved a prospectus for initial public offering of warrants with an issue price of BGN 0.28 and a total number of 44 932 633 warrants. The prospectus has been filed for approval with the Financial Supervision Commission.

Annexes

File Description

SFA_2021_ BD_Prospectus_filing_EN.pdf The Board of Directors of „Sopharma“ AD approved a prospectus for the issue of warrants

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2021-08-03 Ognian Donev Executive Director

SFA_2021_ BD_Prospectus_filing_EN.pdf

Pobierz